German airline Lufthansa will introduce rapid tests before certain flights to detect Covid-19 in passengers. If the trial, set to start in October, is successful, it will be expanded to Lufthansa subsidiaries Swiss International Air Lines (SWISS) and Edelweiss.This content was published on September 28, 2020 - 12:55
The tests are being developed by the Basel-based pharmaceutical company Roche, according to reports in the NZZ am Sonntag and SonntagsZeitung.
It is unclear on which flights the tests, which could cost around €10 (CHF10.80) per passenger, will be trialled, the papers said. Lufthansa said it was looking into various price models, such as including a certain amount in the ticket price.
The requirement to have a negative Covid-19 test when boarding a plane could allow exemptions from entry bans and compulsory quarantine, the papers wrote.
Zurich Airport is also reportedly examining how to integrate such tests into its operations.
Since July 6 anyone entering Switzerland from a country or area with an increased risk of infection must spend ten days in quarantine and report their arrival to the relevant cantonal authority within two days or face a fine.
The economic repercussions of the coronavirus have caused turnover at SWISS to fall by 55% in the first half of 2020. Last month CEO Thomas Klühr warned that the company was still losing a massive amount of money and a return to profitable flights was likely to take time.